A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

• Status: Completed
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to assess steroid induced skin atrophy by sonography.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: LEO Pharma
• Treatments: Betamethasone; Betamethasone benzoate; Betamethasone sodium phosphate; Betamethasone Valerate; Betamethasone-17,21-dipropionate; Clobetasol; Petrolatum

Criteria

Inclusion Criteria:

1. Healthy male volunteers, 25 to 40 years old inclusive.

2. Healthy skin on volar arms with a hairless area sufficient for measurements

Exclusion Criteria:

1. Clinical skin atrophy, telangiectasia or striae on volar arms.

2. Presence of any skin condition or colouration that would interfere with test sites or the response or assessment.

3. Fitzpatrick skin type IV - VI.

4. History or current evidence of infection, eczema or other relevant skin disease.